Cell manufacturing and process development services for RSA PCT0001-01:hesc and ipsc derived CM cell production

Ended Awarded Last action

Contract number
HHSN26800004
Awardee
Awarding agency
Obligated
$662,778

Award facts

Opportunity
  • NHLBIECBHB201609JB Solicitation number
Contract value 100% obligated
$662,778.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Irwindale, CA 91010, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00004 $0
Other Administrative Action P00003 -$1,077,246
Supplemental Agreement for work within scope P00002 · Pact cell processing facility: nhlbi-001: gene modification of hematopoietic stem cells for sickle cell disease correction $0
Supplemental Agreement for work within scope P00001 · Cell manufacturing and process development svcs.: nhlbi-001: gene modification of hematopoietic stem cells for sickle cell disease correction $0
Original award $1,740,024

About this award

This delivery order for $662,778.28 was awarded against the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) master IDIQ by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Beckman Research Institute Of The City Of Hope, a nonprofit organization located in Irwindale, California. The order is for cell manufacturing and process development services for research stem cell-derived cardiomyocyte cell production in support of the PACT-CPF program, with a period of performance through March 31st, 2022. No set-aside designation was used for this award. Beckman Research Institute will utilize its expertise in cell therapies and process development to provide specialized services that further the National Heart Lung and Blood Institute's goals of supporting research in regenerative medicine and new treatment options for cardiovascular diseases.

Quick answers

Who was awarded contract HHSN26800004?

HHSN26800004 was awarded to Beckman Research Institute Of The City Of Hope by National Heart Lung and Blood Institute (National Institutes of Health) on September 29, 2017.

How much is contract HHSN26800004 worth?

The government has obligated $662,778 on HHSN26800004.

Is contract HHSN26800004 an order under another contract?

Yes. HHSN26800004 is a delivery order under HHSN268201600011I, an indefinite delivery contract, on Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).

Was contract HHSN26800004 competed?

The extent of competition for HHSN26800004 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award